Medivation, Inc. (NASDAQ:MDVN) and Astellas (ALPMY) released that it aims to initiate a global Phase 3 clinical examination that will assess the efficacy and safety of enzalutamide in patients with high-risk, hormone-sensitive, non-metastatic prostate cancer that has biochemically recurred after definitive local therapy with radical prostatectomy and/or radiation therapy. Medivation, Inc. (NASDAQ:MDVN) stock hit highest price at $108.835, beginning with a price of $104.37 to the closed at 105.70 by a gain of 2.88% with a day range of $103.21-$108.835. The total market capitalization remained 8.116 Billion, total volume of 1.58 Million shares held in the session was surprisingly higher than its average volume of 1169.60 shares.CommScope Holding Company, Inc. (NASDAQ:COMM) released that its third quarter earnings of $0.62 a share, $0.05 improved than the Capital IQ Consensus anticipates of $0.57. The firm issues downside outlook for Q4, sees EPS of $0.30-$0.35 as compared to $0.47 Capital IQ Consensus Estimate. Shares of CommScope Holding Company, Inc. (NASDAQ:COMM) opened at $21.60 with 187.21 million outstanding shares and hit to its highest price of $22.66 during the day and finally closed at $21.54 by scoring -7.35%. In the whole session, it traded on volume of 6.24 Million shares, which turned higher than its average volume.58.com Inc. (NYSE:WUBA) released that the hired of Mr. Frank Lin as the chairman of the nominating and corporate governance committee as well as the resignation of Mr. Jinbo Yao from his release as a member of the nominating and corporate governance committee. On the other consideration, 58.com Inc. (NYSE:WUBA) begun last trade with a price of $38.62 and throughout the trading session climbed at $40.00. The day-trade ended with an increase of 3.86% to closed at $39.57. The stock is going forward its fifty-two week low with 87.09% and lagging behind from its 52 week high price with -32.81%. WUBA last month stock price volatility remained 4.35%.






